As France's leading biocluster, Genopole is an incubator for cutting-edge projects in biotechnology. Located in the city of Évry, just south of Paris, Genopole provides a unique environment for scientists and entrepreneurs seeking to advance research and innovation.

Discover >


Genopole accompanies researchers, postdocs and start-up entrepreneurs through all the phases of their projects to ensure the best possible conditions for business development.

Discover >

Genopole’s citizens

Every day, at Genopole, researchers, entrepreneurs and students cross paths, share ideas and unite forces in a veritable melting pot for innovation.

Discover >


Giving wings to research and empowering employment in our community are cornerstones of Genopole's mission. Catch up on recent scientific advances, the accomplishments of our biotech actors and the events that enliven the biocluster.

Discover >

Innovate with us

Discover >


1 bis rue de l’Internationale – BP 60
91002 EVRY Cedex – FRANCE
Phone: +33 1 69 47 12 85

Laurence TIENNOT-HERMENT: President
Web Site >
Genethon Laboratory Genethon Laboratory

#Health / Well-being #Health / Well-being

  • Rare diseases
  • Biotherapies
  • Neuromuscular diseases
  • Gene therapy
  • Preclinical and clinical development

Field of Activity

Discovery, development and production of innovative therapies for rare genetic diseases, notably neuromuscular diseases.


Dedicated to the fight against rare diseases, Genethon has developed a unique expertise in the design and development of gene therapy products, from lab research to clinical trials. Its work work has led to several treatments on the market, in clinical trials, or at the R&D stage that are changing the lives of patients and their families.

With 200 scientists and professionals, Genethon pursues its mission: to develop treatments that change the lives of patients suffering from rare genetic diseases and to eradicate these diseases.

Genethon is a non-profit organization, created in 1990 by the French Association against Myopathies (AFM-Téléthon), thanks to donations from the first Telethons.

Description of the Products / Services / Technology

Genethon’s capabilities encompass all the expertise and skills involved in the discovery, preclinical, clinical and technological development, and biomanufacturing of gene therapy vectors:

Therapeutic Research departments:
design gene therapy approaches for several diseases.

Preclinical development, an in vitro and in vivo drug testing platform, which includes:

  • a vivarium hosting up to 4,000 rodents;
  • a functional investigation facility;
  • an imaging and cytometry platform, for molecular and physio-pathological investigation, from the single cell to the whole animal level;
  • a histology service.

Technological developments for gene therapy products:

  • bioprocess R&D;
  • identification and development of biological markers and theranostics
  • for monitoring neuromuscular diseases (Duchenne muscular dystrophy,in particular).

GMP biomanufacturing department:

  • GMP Production, Quality control and Assurance of clinical batches of drug candidates for gene therapy trials.
  • Clinical Development and Regulatory Affairs department: design, implementation and running of clinical trials.

DNA and cell bank:
national platform for the preparation and conservation of human biological samples.

  • Further information

    17 new patents filed in 2020

    22scientific publications in 2020.

    190 staff members (31/12/2020).

    10 Ongoing international gene therapy clinical trials and a portfolio of candidates at various preclinical stages.

Genopole’s Companies

#Health / Well-being

In same field

DeepTope - Genopole's company


– Characterization of antigen / antibody interactions (epitope / paratope) – Optimization of therapeutic antibodies

Theranovir - Genopole's Company


Biotechnology, R&D, Drug development, oncology, obesity, infectious diseases

Cell Environment - Genopole's company

Cell Environment

Cell Environment is a company focusing on DNA damage detection involving unique and repeated sequences such as telomere and centromere sequences.

Innovhem - Entreprise génopolitaine


Our mission is to improve the management of Red Blood Cell diseases and in particular Sickle Cell Disease

Whitelab Genomics - Genopole's Company

WhiteLab Genomics

Artificial intelligence to optimize and accelerate the development of gene therapies

Vaccinopole - entreprise génopolitaine


Production of BCG vaccines and BCG-based cancer and inflammation treatments, preparation and distribution of fresh log-phase BCG cultures.

Traaser - Genopole's Company


Software for biomedical data analysis

Synsight - Genopole's Company


Synsight is a company specializing in the discovery and preclinical development of new therapeutic molecules, based on a proprietary, integrated platform, combining artificial intelligence, molecular modeling and a functional experimental screening approach of High-Content Screening (HCS ).

Sebia - Genopole's Company


Design, manufacture and commercialization of in vitro diagnostic systems (instruments and reagents) for medical biology laboratories.

Santen - Genopole's Company


Santen SAS has developed its own sales force to commercialize ophthalmic products in France while Novagali Innovation Center is a center of excellence for Santen Group dedicated to research and development of innovative ophthalmic treatments for all segments of the eye.

Pharnext - Genopole's company

Pharnext SA

Pharnext develops new therapies and biomarkers based on network pharmacology with a proprietary discovery platform. The company is focused on pathologies with high unmet medical needs. These include neurodegenerative, orphan and common diseases (Charcot-Marie-Tooth disease Type 1A, Alzheimer’s disease, Parkinson’s disease, amyotrophic lateral sclerosis (ALS)).

PEP-Therapy - Genopole's Company - logo 2021


PEP-Therapy develops innovative peptides as targeted therapies in oncology. The company operates a unique therapeutic technology based on cell penetrating & interfering peptides (CP&IP). These innovative molecules penetrate cells and specifically block relevant intracellular protein-protein interactions, thus inhibiting key pathological mechanisms.

LPS Biosciences - Genopole's company


LPS-BioSciences is specialized in bacterial endotoxins. It combines an exclusive proprietary technology for endotoxin production and characterization. and its acquired experience in the fields of vaccines, diagnostics, and the food industry.

Logo Integragen - Genopole's Company


IntegraGen’s mission is to translate molecular research to clinical practice through the identification of novel genetic biomarkers and the subsequent commercialization of molecular diagnostic tests based on these discoveries.

Enterome - Genopole's company


Enterome develops and commercializes therapies for disorders associated with disruption of the intestinal microbiota.

Endodiag - Genopole's company


Design, development and commercialization of medical devices and services for the diagnosis of endometriosis.

Enalees - Genopole's company


Enalees conceives, develops and markets next-generation rapid molecular diagnosis tests for veterinarians, and furthermore screening tests for SARS-CoV-2.

Algobiotech - Genopole's company


Research and valorization of microalgae for cosmetic, nutraceutic and therapeutic applications.

AiiNTENSE - Genopole's company


AiiNTENSE provides a complete cognitive assistance solution to improve the medical, ethical and economic management of patients in intensive care units.

logo abcell Bio - Genopole's Companie


Abcell-bio is a laboratory specializing in the isolation of human hematopoietic stem cells and primary cells derived from perinatal tissue and cord blood.

View all >
With the support from